Find Federal Grants
Agency for International Development · 72DFFP18RFA00002
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
National Institutes of Health · PAR-18-744
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
National Institutes of Health · PAR-18-743
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-005
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health · PA-18-741
National Institutes of Health · PAR-18-740
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
National Institutes of Health · PAR-18-727
National Institutes of Health · PAS-18-730
Agency for International Development · 7200AA18R00032
Exploration of HL7 FHIR Standards for Clinical Research and Post-market Surveillance (U24)
Food and Drug Administration · RFA-FD-18-016
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
National Institutes of Health · PA-18-720
Food and Drug Administration · RFA-FD-18-021
Renewal Applications: Centers of Excellence in Regulatory Science and Innovation (U01)
Food and Drug Administration · RFA-FD-18-011
Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Non-Invasive Techniques (U01)
Food and Drug Administration · RFA-FD-18-012
Computational fluid dynamics (CFD) and discrete element modeling (DEM) approach for predictions of dry powder inhaler (DPI) drug delivery (U01)
Food and Drug Administration · RFA-FD-18-014
Three-Dimensional Approach for Modeling Nasal Mucociliary Clearance via Computational Fluid Dynamics (CFD) (U01)
Food and Drug Administration · RFA-FD-18-020
Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)
Food and Drug Administration · RFA-FD-18-019
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations (U01)
Food and Drug Administration · RFA-FD-18-010
Characterize skin physiology parameters utilized in dermal physiologically-based pharmacokinetic model development across different skin disease states (U01)
Food and Drug Administration · RFA-FD-18-017
Food and Drug Administration · RFA-FD-18-015